Our Journey
1989
![](https://suvenpharm.com/wp-content/uploads/2022/12/chemGreen-92x300.png)
Generic APIs
1992
![](https://suvenpharm.com/wp-content/uploads/2022/12/chemBlue-91x300.png)
Complex Chemicals
1995
![](https://suvenpharm.com/wp-content/uploads/2022/12/chemGreen-92x300.png)
Contract Research & Manufacturing Services (CRAMS)
2003
![](https://suvenpharm.com/wp-content/uploads/2022/12/chemBlue-91x300.png)
In-house Drug Discovery
2005
![](https://suvenpharm.com/wp-content/uploads/2022/12/chemGreen.png)
Development of NCE SUVN-502
2006
![](https://suvenpharm.com/wp-content/uploads/2022/12/chemBlue-91x300.png)
Drug Discovery and Services
2014
![](https://suvenpharm.com/wp-content/uploads/2022/12/chemGreen-92x300.png)
3 CRAMS projects commercialized
2019
![](https://suvenpharm.com/wp-content/uploads/2022/12/chemBlue-91x300.png)
1 more CRAMS project and 1 more specialty chem project commercialized
2020
![](https://suvenpharm.com/wp-content/uploads/2022/12/chemGreen-92x300.png)
Demerged into 2 Companies. Commencement of Suven Pharma, a resultant company out of Demerger
2022
![](https://suvenpharm.com/wp-content/uploads/2022/12/chemBlue-91x300.png)
Acquires Casper Pharma
Our Milestones
1989
Generic APIs![](https://suvenpharm.com/wp-content/uploads/2022/10/RR-14.jpg)
1992
Complex Chemicals![](https://suvenpharm.com/wp-content/uploads/2022/10/RR-19.jpg)
1995
Contract Research & Manufacturing Services (CRAMS)![](https://suvenpharm.com/wp-content/uploads/2022/10/RR-4.jpg)
2003
In-house Drug Discovery![](https://suvenpharm.com/wp-content/uploads/2022/10/RR-32.jpg)
2005
Initiation of CNS programs with SUVN-502 as a lead molecule![](https://suvenpharm.com/wp-content/uploads/2022/10/RR-10.jpg)
2006
Drug Discovery and Services![](https://suvenpharm.com/wp-content/uploads/2022/10/RR-13.jpg)
2014
3 CRAMS projects commercialized![](https://suvenpharm.com/wp-content/uploads/2022/10/milestone7.jpg)
2019
1 more CRAMS project and 1 more specialty chem project commercialized![](https://suvenpharm.com/wp-content/uploads/2022/10/milestone8.jpg)
2020
Demerged into 2 Companies. Commencement of Suven Pharma, a resultant company out of Demerger![](https://suvenpharm.com/wp-content/uploads/2022/10/milestone9.jpg)
Previous
Next
1989
Generic API
1995
Contract Research & Manufacturing Services (CRAMS)
2005
Initiation of CNS programs with SUVN-502 as a lead molecule
2014
3 CRAMS projects commercialized
2020
Demerged into 2 Companies. Commencement of Suven Pharma, a resultant company out of Demerger
1992
Complex Chemicals
2003
In-house Drug Discovery
2006
Drug Discovery and Services
2019
1 more CRAMS project and 1 more specialty chem project commercialized
![Health Canada[268]](https://suvenpharm.com/wp-content/uploads/2022/11/Health-Canada268.png)
![ANVISA](https://suvenpharm.com/wp-content/uploads/2022/11/ANVISA.jpg)
![download](https://suvenpharm.com/wp-content/uploads/2022/11/download.jpg)
![download](https://suvenpharm.com/wp-content/uploads/2022/11/download.png)
![FDA](https://suvenpharm.com/wp-content/uploads/2022/11/FDA.jpg)
![kfda](https://suvenpharm.com/wp-content/uploads/2022/11/kfda.png)
![tfda](https://suvenpharm.com/wp-content/uploads/2022/11/tfda.png)
![OGYEIlogo_2](https://suvenpharm.com/wp-content/uploads/2023/06/OGYEIlogo_2.jpg)